The Fort Worth Press - Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting

USD -
AED 3.672498
AFN 66.135424
ALL 82.428003
AMD 381.697608
ANG 1.790403
AOA 917.000333
ARS 1440.719298
AUD 1.503556
AWG 1.8
AZN 1.698617
BAM 1.6671
BBD 2.013298
BDT 122.155689
BGN 1.666095
BHD 0.376959
BIF 2954.536737
BMD 1
BND 1.290974
BOB 6.906898
BRL 5.403152
BSD 0.999616
BTN 90.396959
BWP 13.244683
BYN 2.94679
BYR 19600
BZD 2.010374
CAD 1.37658
CDF 2240.000343
CHF 0.795735
CLF 0.023238
CLP 911.629427
CNY 7.054505
CNH 7.041445
COP 3801.6
CRC 500.023441
CUC 1
CUP 26.5
CVE 93.988535
CZK 20.66805
DJF 178.007927
DKK 6.35678
DOP 63.547132
DZD 129.654932
EGP 47.449851
ERN 15
ETB 156.189388
EUR 0.850931
FJD 2.253797
FKP 0.748248
GBP 0.74691
GEL 2.70203
GGP 0.748248
GHS 11.474844
GIP 0.748248
GMD 73.000007
GNF 8692.206077
GTQ 7.656114
GYD 209.124811
HKD 7.78223
HNL 26.31718
HRK 6.410897
HTG 131.023872
HUF 327.803501
IDR 16673.45
ILS 3.20699
IMP 0.748248
INR 90.72575
IQD 1309.438063
IRR 42122.494452
ISK 126.299846
JEP 0.748248
JMD 160.047735
JOD 0.708952
JPY 154.966501
KES 128.950385
KGS 87.449685
KHR 4002.062831
KMF 419.501996
KPW 899.999687
KRW 1464.35502
KWD 0.30682
KYD 0.833039
KZT 521.320349
LAK 21670.253798
LBP 89512.817781
LKR 308.871226
LRD 176.427969
LSL 16.864406
LTL 2.95274
LVL 0.60489
LYD 5.429826
MAD 9.19607
MDL 16.897807
MGA 4428.248732
MKD 52.4169
MMK 2099.265884
MNT 3545.865278
MOP 8.015428
MRU 40.004433
MUR 45.950131
MVR 15.398937
MWK 1733.36743
MXN 17.978805
MYR 4.0925
MZN 63.910031
NAD 16.864406
NGN 1451.530241
NIO 36.789996
NOK 10.13585
NPR 144.638557
NZD 1.725615
OMR 0.384498
PAB 0.999595
PEN 3.365397
PGK 4.308177
PHP 58.924995
PKR 280.140733
PLN 3.59277
PYG 6714.401398
QAR 3.643004
RON 4.335502
RSD 99.943984
RUB 79.121636
RWF 1454.886417
SAR 3.752081
SBD 8.176752
SCR 14.658273
SDG 601.499594
SEK 9.28439
SGD 1.288906
SHP 0.750259
SLE 24.125013
SLL 20969.503664
SOS 570.259558
SRD 38.547979
STD 20697.981008
STN 20.880385
SVC 8.746351
SYP 11056.681827
SZL 16.85874
THB 31.431503
TJS 9.186183
TMT 3.51
TND 2.922143
TOP 2.40776
TRY 42.701498
TTD 6.783302
TWD 31.318031
TZS 2482.490189
UAH 42.236116
UGX 3552.752147
UYU 39.226383
UZS 12042.534149
VES 267.43975
VND 26320
VUV 121.127634
WST 2.775483
XAF 559.141627
XAG 0.015656
XAU 0.00023
XCD 2.70255
XCG 1.801522
XDR 0.695393
XOF 559.141627
XPF 101.655763
YER 238.499715
ZAR 16.776101
ZMK 9001.197187
ZMW 23.065809
ZWL 321.999592
  • RIO

    -1.0800

    75.66

    -1.43%

  • CMSC

    -0.1300

    23.3

    -0.56%

  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.0000

    81.17

    0%

  • BCC

    0.2500

    76.51

    +0.33%

  • RYCEF

    -0.2500

    14.6

    -1.71%

  • BTI

    -1.2700

    57.1

    -2.22%

  • NGG

    0.2400

    74.93

    +0.32%

  • BCE

    0.3100

    23.71

    +1.31%

  • CMSD

    -0.1500

    23.25

    -0.65%

  • RELX

    0.1000

    40.38

    +0.25%

  • GSK

    -0.0700

    48.81

    -0.14%

  • JRI

    -0.0200

    13.7

    -0.15%

  • VOD

    0.0500

    12.59

    +0.4%

  • BP

    -0.2700

    35.26

    -0.77%

  • AZN

    -0.4600

    89.83

    -0.51%

Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting
Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting

Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative Health Reporting

LAS VEGAS, NV / ACCESS Newswire / May 20, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are in talks with an international healthcare innovation company to license or potentially acquire its patented early disease detection technology. If successful, it's a global license or acquisition that has the potential to revolutionize preventive health reporting and to generate correlations for future detection of new diseases without the need for all the patient's data.

Text size:

Avant and Ainnova continue to grow the footprint and capabilities of their technology portfolio with the goal of being a leader in early disease detection using the Company's signature AI-driven Vision AI technology platform.

Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the Company's aim to continue to add to its portfolio, "Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily. We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem.

"To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions."

Avant and Ainnova see the retina as a new vital sign, but also understand that leveraging the results of laboratory tests and basic patient data can all work in concert to provide a comprehensive health report.

Vargas added, "We have already integrated an exclusive license for four algorithms into our Vision AI platform, and we are now in talks to license and potentially acquire an innovative technology that would be a game changer in our industry."

Avant will inform its shareholders of any updates at an appropriate time.

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI

https://linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies Inc.
[email protected]

SOURCE: Avant Technologies



View the original press release on ACCESS Newswire

C.Rojas--TFWP